Table 2.
Treatment | Dose (mg/ml) | Normalised survival time (hour) in mean ± SD | t value | t critical value |
---|---|---|---|---|
Control | 0 | 100.00 ± 2.00 | NA | NA |
Albendazole | 1.25 | 024.07 ± 1.62* | 114.35 | 2.05 |
2.5 | 020.51 ± 1.21* | 131.56 | 2.07 | |
5 | 016.56 ± 0.99* | 144.85 | 2.08 | |
10 | 012.22 ± 1.05* | 150.56 | 2.08 | |
20 | 004.70 ± 0.84* | 170.05 | 2.09 | |
I. cylindrica extract | 1.25 | 091.81 ± 2.36* | 010.25 | 2.05 |
2.5 | 089.40 ± 1.71* | 015.60 | 2.05 | |
5 | 082.48 ± 3.02* | 018.74 | 2.06 | |
10 | 064.73 ± 2.55* | 042.15 | 2.06 | |
20 | 036.53 ± 2.67* | 073.85 | 2.06 |
NA Not applicable; n = 15; t value is the calculated difference represented in units of standard error, the higher the value, the greater the evidence against the null hypothesis; t critical value denotes the value that must be exceeded to get a significant level
*Significantly different at p < 0.05 against control